NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Natera, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$399.42+5.98 (+1.52%)
Close on Oct 19, 2026
- Market cap
- $57.23B
- P/E (TTM)
- –
- Dividend yield
- –
Natera, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenues | $2.30B | $1.69B | $1.07B | $797.31M | $580.08M | $377.88M | $269.88M | $240.37M | $203.78M | $209.41M | 99.6% | +36.2% |
| Licensing and other revenues | $10.29M | $11.84M | $14.05M | $22.92M | $45.41M | $13.13M | $32.45M | $17.29M | $5.85M | $3.11M | 0.4% | -13.0% |
| Constellation | – | – | – | – | – | – | – | $4.84M | $4.23M | $3.11M | – | – |
| HCS | – | – | – | – | – | – | – | $87.17M | $63.47M | $56.42M | – | – |
| Other genetic tests | – | – | – | – | – | – | – | $12.26M | $11.41M | $12.41M | – | – |
| Panorama NIPT | – | – | – | – | – | – | – | $140.93M | $128.90M | $140.58M | – | – |
| Other product | – | – | – | – | – | – | – | $6.65M | $1.62M | – | – | – |
| Other, licensing and other | – | – | – | – | – | – | $10.98M | $6.65M | $1.62M | – | – | – |
| Upfront license and constellation and paternity | – | – | – | – | – | – | $5.09M | $10.34M | $4.23M | – | – | – |
| Qiagen | – | – | – | – | – | – | – | $5.79M | – | – | – | – |
| License and development services | – | – | – | – | – | – | $16.38M | $294.00K | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $2.26B | $1.66B | $1.05B | $785.85M | $590.87M | $365.66M | $260.85M | $225.93M | $185.53M | $188.49M | 98.2% | +36.6% |
| Europe, Middle East, India, and Africa | $24.48M | $23.88M | $22.81M | $16.64M | $20.43M | $14.33M | $15.43M | $20.87M | $14.00M | $14.26M | 1.1% | +2.5% |
| Americas, excluding U.S. | $9.35M | $6.62M | $4.91M | $3.71M | $4.05M | $3.47M | $3.22M | $3.47M | $3.03M | $2.56M | 0.4% | +41.3% |
| Asia Pacific and Other | $8.01M | $8.66M | $7.22M | $14.03M | $10.14M | $7.54M | $22.83M | $7.39M | $7.07M | $7.20M | 0.3% | -7.5% |
| XX | – | – | – | – | – | – | – | – | $7.07M | $7.20M | – | – |
From the segment and revenue-disaggregation notes of Natera's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.